University of Iowa Adult Comprehensive Simulation-Based ECMO Course

Tuesday, April 16, 2024, 8:00 AM - Friday, April 19, 2024, 12:00 PM, Heart & Vascular Conf Rm (4999 JPP), Iowa City, IA

The University of Iowa’s ECMO program has been offering ECMO courses since 2009. We are proud to offer this ELSO Endorsed ECMO Training Course which is intended to train all levels of ECMO providers (APP, CCP, Physician, RN, RRT) through a combination of didactic presentations and high-fidelity simulation. This course will fullfil the requirements for Step 1 and Step 2 of the E-AEC certification. Course content includes management of VenoVenous and VenoArterial ECMO.

AMA PRA Category 1 Credits™ (21.25 hours), ANCC Contact Hours (21.25 hours), Non-Physician Attendance (21.25 hours)

1. Identify the overview and history of Extracorporeal Membrane Oxygneation (ECMO).
2. Describe ECMO components and monitoring tools.
3. Identify the steps of cannulation for Venovenous (V-V) and Venoarterial (V-A) ECMO
4. Contrast V-V and V-A ECMO configurations
5. Identify ECMO complications
6. Describe gas transfer in the membrane lung
7. Compare hemodynamic monitoring during V-V and V-A ECMO
8. Define and identify drainage insufficiency, return obstruction, and recirculation
9. Define and identify ECMO emergencies
10. Discuss respiratory failure and the role of ECMO
11. Discuss cardiac failure and the role of ECMO
12. Describe patient selection for V-V and V-A ECMO
13. Describe initiation, maintenance, and weaning of V-V and V-A ECMO
14. Explain left ventricular distention
15. Describe differential oxygenation
16. Discuss the role of sedation, physiotherapy, and anticoagulation during ECMO
17. Review considerations for procedures on the ECMO patient
18. Describe the role of renal replacement therapy during ECMO
19. Discuss intrahospital and interhospital ECMO transport
20. Review historical and recent evidence for V-V and V-A ECMO

Registration Fees
Full Registration - Didactic + Simulation $2500
Simulation Only   $1500
Didactic Only $1000
UI Staff and Fellows $500

In support of improving patient care, the University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician:  The University of Iowa Carver College of Medicine designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse:  The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 21.25 ANCC contact hours.

Other Provider:  All other participants will receive a certificate of participation for this conference upon completion of the online evaluation.   It is the responsibility of each attendee to determine if the continuing education programs they attend meet the requirements of their professional licensure board.

DISCLOSURE POLICY:  University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.